Roche Chairman: Broad Pipeline Can Cushion Blow From Cancer Setback
ZURICH (Reuters) – Roche administrative-board Chairman Christoph Franz said on Thursday a wide product development pipeline at the Swiss pharma and diagnostics company would offset the loss in growth prospects from a failure in immuno-oncology development this week. Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when immunotherapy…
